# A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis

> **NCT00800202** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 91 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** bevacizumab [Avastin]
- **DRUG:** carboplatin
- **DRUG:** erlotinib [Tarceva]
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00800202
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2014-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800202, "A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00800202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*